Astrotech (NASDAQ: ASTC) will demonstrate 1st Detect’s mass spectrometry-based explosives and narcotics detector, the TRACER 1000, at Stand 529 at the Border Security Expo (BSE) in San Antonio, TX from Jan. 31st to Feb. 2nd, 2018.
Astrotech (NASDAQ: ASTC) completed a successful 1st Detect demo with DHS and TSA personnel; TRACER 1000 to be demonstrated at their annual meeting of shareholders on Dec. 7th in Austin, TX.
Astrotech (NASDAQ: ASTC) subsidiary 1st Detect has entered into a Cooperative Research and Development Agreement with the DHS S&T Transportation Security Laboratory.
Astrotech (NASDAQ: ASTC) subsidiary 1st Detect, in collaboration with The University of Texas Health Science Center, now called UT Health San Antonio, announced positive preliminary results in pre-clinical trials for the BreathDetect 1000 – a rapid bedside breathalyzer for detecting bacterial infections in the respiratory tract, such as hospital-acquired pneumonia (HAP).
Astrotech Corporation’s (NASDAQ: ASTC) board of directors and management announce that they have engaged Chardan to advise on strategic alternatives involving Astrotech subsidiary 1ST Detect Corporation, a manufacturer of advanced mass spectrometry technology used to detect and analyze trace levels of explosives, chemical warfare agents (CWAs), and volatile organic compounds (VOCs).